Literature DB >> 17203355

Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients.

Irfan H Atakan1, Mustafa Kaplan, Gulay Seren, Tevfik Aktoz, Hatice Gül, Osman Inci.   

Abstract

Many theories have been put forward to explain the mechanism of stone formation and growth. The aim of this study was to investigate the urinary, serum and stone levels of zinc, iron, magnesium, and copper in patients with calcium oxalate stones and to investigate urinary and serum element levels in healthy controls and to find a possible connection between the elements and calcium oxalate stone formation. A total of 104 patients with calcium oxalate stones ranging in age from 3 to 79 years (mean 44.0 +/- 18.1) and 77 healthy controls ranging in age from 18 to 77 (mean 44.2 +/- 17.9) were included in this study. The mean urinary iron and copper levels in stone patients were significantly higher than healthy controls (P = 0.000). The mean urinary zinc and magnesium levels in healthy controls were significantly higher than stone patients (P = 0.000). There was no significant difference in the serum levels of magnesium and copper in stone patients and healthy controls. Serum zinc and iron level were significantly high in healthy controls as compared to stone patients. Each stone had all 4 elements. Zn and Mg have inhibitory effect on calcium oxalate stone formation. Fe and Cu could be promotor of the calcium oxalate stone formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17203355     DOI: 10.1007/s11255-006-9050-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  25 in total

1.  Role of urinary zinc and copper on calcium oxalate stone formation.

Authors:  Taner Ozgurtas; Gurer Yakut; Mahir Gulec; Muhittin Serdar; Turker Kutluay
Journal:  Urol Int       Date:  2004       Impact factor: 2.089

2.  The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers.

Authors:  A Trinchieri; A Mandressi; P Luongo; G Longo; E Pisani
Journal:  Br J Urol       Date:  1991-03

3.  A quantitative investigation of the effects on the growth of calcium oxalate crystals on potential inhibitors.

Authors:  S G Welshman; M G McGeown
Journal:  Br J Urol       Date:  1972-12

4.  The urinary excretion of trace metals in patients with calcium oxalate urinary stone.

Authors:  J S Elliot; M E Ribeiro
Journal:  Invest Urol       Date:  1973-01

5.  The effects of magnesium and pH on experimental calcium oxalate stone disease.

Authors:  T A Borden; E S Lyon
Journal:  Invest Urol       Date:  1969-01

6.  Serum and urinary zinc levels in urolithiasis.

Authors:  G V Rangnekar; M S Gaur
Journal:  Br J Urol       Date:  1993-05

7.  Trace element investigations in kidney stone patients.

Authors:  J Joost; R Tessadri
Journal:  Eur Urol       Date:  1987       Impact factor: 20.096

8.  Inhibitors of urinary stone formation in 40 recurrent stone formers.

Authors:  B François; R Cahen; B Pascal
Journal:  Br J Urol       Date:  1986-10

9.  The role of trace metals in calcium urolithiasis.

Authors:  J L Meyer; E E Angino
Journal:  Invest Urol       Date:  1977-03

10.  Effects of magnesium on calcium oxalate crystallization.

Authors:  M K Li; N J Blacklock; J Garside
Journal:  J Urol       Date:  1985-01       Impact factor: 7.450

View more
  21 in total

1.  Antioxidants inhibition of high plasma androgenic markers in the pathogenesis of ethylene glycol (EG)-induced nephrolithiasis in Wistar rats.

Authors:  Mohammad Reza Naghii; Mahmood Mofid; Mehdi Hedayati; Kazem Khalagi
Journal:  Urolithiasis       Date:  2013-11-08       Impact factor: 3.436

2.  Does smoking have any effect on urinary stone composition and the distribution of trace elements in urine and stones?

Authors:  Marcin Słojewski; Bogusław Czerny; Krzysztof Safranow; Marek Droździk; Andrzej Pawlik; Katarzyna Jakubowska; Maria Olszewska; Adam Gołab; Elzbieta Byra; Dariusz Chlubek; Andrzej Sikorski
Journal:  Urol Res       Date:  2009-10-14

3.  Urinary stones as a novel matrix for human biomonitoring of toxic and essential elements.

Authors:  J Kuta; S Smetanová; D Benová; T Kořistková; J Machát
Journal:  Environ Geochem Health       Date:  2015-03-04       Impact factor: 4.609

4.  Association of minor and trace elements with mineralogical constituents of urinary stones: a hard nut to crack in existing studies of urolithiasis.

Authors:  J Kuta; J Machát; D Benová; R Červenka; J Zeman; P Martinec
Journal:  Environ Geochem Health       Date:  2013-02-22       Impact factor: 4.609

5.  Laser-induced breakdown spectroscopy is a reliable method for urinary stone analysis.

Authors:  Nazım Mutlu; Seyfettin Çiftçi; Turgay Gülecen; Belgin Genç Öztoprak; Arif Demir
Journal:  Turk J Urol       Date:  2016-03

6.  Dietary Zinc and Incident Calcium Kidney Stones in Adolescence.

Authors:  Gregory E Tasian; Michelle E Ross; Lihai Song; Robert W Grundmeier; James Massey; Michelle R Denburg; Lawrence Copelovitch; Steven Warner; Thomas Chi; David W Killilea; Marshall L Stoller; Susan L Furth
Journal:  J Urol       Date:  2016-11-23       Impact factor: 7.450

7.  Trace elements in urinary stones: a preliminary investigation in Fars province, Iran.

Authors:  Behnam Keshavarzi; Nasrin Yavarashayeri; Dariush Irani; Farid Moore; Alireza Zarasvandi; Mehrdad Salari
Journal:  Environ Geochem Health       Date:  2014-11-30       Impact factor: 4.609

8.  Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review.

Authors:  Vivek K Singh; Pradeep K Rai
Journal:  Biophys Rev       Date:  2014-07-31

9.  Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats.

Authors:  Mohammad Reza Naghii; Eslam Eskandari; Mahmood Mofid; Mehdi Jafari; Mohammad Hossein Asadi
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

Review 10.  The elementome of calcium-based urinary stones and its role in urolithiasis.

Authors:  Krishna Ramaswamy; David W Killilea; Pankaj Kapahi; Arnold J Kahn; Thomas Chi; Marshall L Stoller
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.